An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells

Authors

  • Hisashi Moriguchi,

    1. Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan
    2. Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    3. Department of Analytical Health Science, Graduate School of Health Sciences, Tokyo Medical and Dental University, Tokyo, Japan
    Search for more papers by this author
  • Raymond T. Chung,

    1. Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    Search for more papers by this author
  • Chifumi Sato

    1. Department of Analytical Health Science, Graduate School of Health Sciences, Tokyo Medical and Dental University, Tokyo, Japan
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

No abstract is available for this article.

Ancillary